Targeting HER2+ Breast Cancer: The TBK1/IKK-Epsilon Axis

Oncoscience - United States
doi 10.18632/oncoscience.18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Impact Journals, LLC

Related search

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer

Scientific Reports
Multidisciplinary
2017English

Targeting the Ron-Dek Signaling Axis in Breast Cancer

2013English

Targeting Sphingosine-1-Phosphate Axis in Obesity-Promoted Breast Cancer

2016English

The UPR Inducer DPP23 Inhibits the Metastatic Potential of MDA-MB-231 Human Breast Cancer Cells by Targeting the Akt–IKK–NF-κB–MMP-9 Axis

Scientific Reports
Multidisciplinary
2016English

HER2 Signaling Pathway Activation and Response of Breast Cancer Cells to HER2-targeting Agents Is Dependent Strongly on the 3D Microenvironment

Breast Cancer Research and Treatment
Cancer ResearchOncology
2009English

Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer

Oncotarget
Oncology
2017English

Targeting TAZ-driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Erratum To: Targeting the PELP1-KDM1 Axis as a Potential Therapeutic Strategy for Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2012English

circRNA‑CER Mediates Malignant Progression of Breast Cancer Through Targeting the miR‑136/MMP13 Axis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy